DelveInsight's Triple-Negative Breast Cancer Market Insights report includes a comprehensive understanding of current ...

Astellas Pharma Inc. rose the most in more than three months after quarterly profit exceeded analysts’ projections, driven by ...

A Chinese court said he had been paid to provide information on China's politics and economy to intelligence agencies.

The ruling on a Japanese businessman who was convicted earlier this month by a Chinese court for engaging in spying and sentenced t ...

Astellas Pharma has entered a memorandum of understanding (MoU) with the Korea Institute of Startup and Entrepreneurship Development (KISED) to support Korean pharmaceutical startups' global growth.

As many as 19 of the top 20 publicly-traded global biopharma companies reported revenue growth in 2024, with an overall 7.9% ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The Astellas employee was sentenced Wednesday to three and a half years in prison by a Beijing court. According to a source familiar with the case, the court ruled that he had passed on Chinese ...

A Beijing district court that imposed the prison sentence is believed to have found the man guilty of espionage for providing ...

As America's population ages, chronic and rare diseases are emerging as a pressing healthcare challenge — one that ...

View the latest Astellas Pharma Inc. (ALPMF) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Astellas' gastric cancer therapy gets UK regulator's nod Britain's health regulator said on Wednesday it has approved Japan-based Astellas Pharma's therapy to treat a type of gastric cancer.